Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization

Bibliographic Details
Main Authors:	Triana Amen, Daniel Kaganovich
Format:	Article
Language:	English
Published:	Shared Science Publishers OG 2016-03-01
Series:	Microbial Cell
Subjects:	yeast drug FDA Alzheimer’s screen amyloid beta
Online Access:	http://microbialcell.com/researcharticles/yeast-screening-platform-identifies-fda-approved-drugs-that-reduce-a%CE%B2-oligomerization/

Similar Items

Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
by: Sei-Kyoung Park, et al.
Published: (2016-01-01)

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
by: Dr. Chenshu Xu, et al.
Published: (2021-09-01)

Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer’s Disease Transgenic Mice
by: Dong-qun Liu, et al.
Published: (2020-07-01)

Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from <em>Entamoeba histolytica</em> and <em>Giardia lamblia </em>Identifies Inhibitors of Their Trophozoite Growth Phase
by: Alfredo Juárez-Saldivar, et al.
Published: (2021-05-01)

Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
by: Sudip Dhakal, et al.
Published: (2019-07-01)

Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
by: Marta Mariniello, et al.
Published: (2020-03-01)

Mechanism mediating oligomeric Aβ clearance by naïve primary microglia
by: Cheng-Ning Yang, et al.
Published: (2011-06-01)

Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast
by: Xin Chen, et al.
Published: (2017-07-01)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
by: Ioana Gherghescu, et al.
Published: (2021-12-01)

Development of Convenient System for Detecting Yeast Cell Stress, Including That of Amyloid Beta
by: Yen Nhi Luu, et al.
Published: (2018-07-01)

<i>Trans</i>-Chalcone Plus Baicalein Synergistically Reduce Intracellular Amyloid Beta (Aβ<sub>42</sub>) and Protect from Aβ<sub>42</sub> Induced Oxidative Damage in Yeast Models of Alzheimer’s Disease
by: Sudip Dhakal, et al.
Published: (2021-08-01)

A rapid absorbance-based growth assay to screen the toxicity of oligomer Aβ42 and protect against cell death in yeast
by: Prashant Bharadwaj, et al.
Published: (2020-01-01)

FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
by: Lauren L. Spiegel, et al.
Published: (2020-05-01)

FDA efficiency for approval process of COVID-19 therapeutics
by: Christine Cassidy, et al.
Published: (2020-12-01)

A Drug Combination Screen Identifies Drugs Active against Amoxicillin-induced Round Bodies of Borrelia burgdorferi Persisters from an FDA Drug Library
by: Jie eFeng, et al.
Published: (2016-05-01)

Screening of an FDA-Approved Library for Novel Drugs against <i>Y. pestis</i>
by: David Gur, et al.
Published: (2021-01-01)

Aggregation Inhibition and Detection of Alzheimer’s Amyloidogenic and Oligomeric Peptides

Acrylamide in Food – EU versus FDA Approaches
by: Gabriel Mustăţea, et al.
Published: (2015-11-01)

Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
by: Jinhua Wen, et al.
Published: (2021-09-01)

Oligomeric amyloid-beta as a potential biomarker for Alzheimer's Disease
Published: (2013)

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
by: Meehyun Ko, et al.
Published: (2021-04-01)

Utility of an improved model of amyloid-beta (Aβ<sub>1-42</sub>) toxicity in <it>Caenorhabditis elegans</it> for drug screening for Alzheimer’s disease
by: McColl Gawain, et al.
Published: (2012-11-01)

Tyramine and Amyloid Beta 42: A Toxic Synergy
by: Sudip Dhakal, et al.
Published: (2020-05-01)

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
by: Arun Bahadur Gurung, et al.
Published: (2020-10-01)

Integrative modules for efficient genome engineering in yeast
by: Triana Amen, et al.
Published: (2017-06-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Effect of Gemini Surfactants on Amyloid Beta Aggregation
by: Bahmani, Mehrnoosh
Published: (2013)

Target Detection Performance Analysis of FDA-MIMO Radar
by: Yu Zhu, et al.
Published: (2019-01-01)

A high throughput drug screening paradigm using transgenic Caenorhabditis elegans model of Alzheimer’s disease
by: Emelyne Teo, et al.
Published: (2020-01-01)

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ
by: William J. Meilandt, et al.
Published: (2019-12-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
by: Shizuo Hatashita, et al.
Published: (2019-09-01)

Synthesis of peptidomimetics containing bifunctional diketoopiperazine scaffolds and their evaluation as modulators of amyloid-B peptide oligomerization
by: Vahdati, Leïla
Published: (2015)

Etude de la structure et de la toxicité des oligomères du peptide amyloïde-beta: implication dans la maladie d'Alzheimer
by: Sarroukh, Rabia
Published: (2011)

Drugs, Devices, and the FDA: Part 1
by: Gail A. Van Norman, MD
Published: (2016-04-01)

Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
by: Daniel A. Rodrigues, et al.
Published: (2019-05-01)

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
by: Ashwini eBenedict, et al.
Published: (2015-07-01)

Review of FDA Public Hearing Transcript on Behind-the-Counter Availability of Certain Drugs
by: Reiss, Matthew, et al.
Published: (2009)

Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
by: George Tetz, et al.
Published: (2021-06-01)

Evaluation of the accordance of panoramic radiography ordering in maxillofacial radiology department, school of dentistry, Tehran university of medical sciences with FDA guidelines in scholar year 200
by: Goodarzi Pour D., et al.
Published: (2007-07-01)

Role of the N-Terminal Hydrophilic Region of Amyloid Beta Peptide in Amyloidogenesis, Membrane Interaction and Toxicity Associated with Alzheimer’s Disease

Cannot write session to /tmp/vufind_sessions/sess_v1aquotiu9h2hsc20cqv6k7v2a